• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Business

New Specsavers report shows impact of eye health strategies

by Myles Hume
November 11, 2019
in Business, Company updates & acquisitions, Local, News
Reading Time: 3 mins read
A A
Share on FacebookShare on Twitter

Specsavers’ latest snapshot into Australian eye health has revealed referrals for eye disease are soaring to unprecedented levels thanks to the systematic use of imaging technology and ophthalmology-led education, as well as other clinical interventions.

In its latest report, titled the Specsavers Eye Health Report 2019-20, the optical chain also details how it is identifying cases of glaucoma much earlier than before, while also bringing its overall detection rates further into line with prevalence estimates.

Released to Insight last week, the report builds on the company’s inaugural State of the Nation Eye Health Report published in October last year. Billed at the time as the most in-depth examination of Australian eye health, it established a yardstick to measure future outcomes against and highlighted the need for greater sector-wide collaboration.

This year Specsavers analysed data from 8.5 million patient journeys to quantify the impact of its strategies, as well as the Australian public’s attitudes towards eye health. It is the largest data-set of its kind available in the region, and this year increased by another 3.5 million data points.

The company reports it is continuing to make significant inroads towards the detection and referral of glaucoma and diabetic eye disease, partially driven by its initiative to use optical coherence tomography (OCT) on every patient.

The figures show glaucoma referrals have doubled over the past two years. Between July and December 2017, when OCT was installed in just 3% of stores, Specsavers referred 10,562 of these patients to ophthalmology. The figure rose to 20,516 between January to June this year, when OCT was incorporated in 83% of practices.

Glaucoma referrals over time, demonstrating the impact of optical coherence tomography.

By 31 July this year, glaucoma referrals had further increased to 24,477. With OCT now available across all 334 Australian stores, referrals are projected to reach 42,000 by the end of the year, an increase of 19% on 2018 (34,053) and 64% on 2017 (15,145).

Overall, 86% of glaucoma referrals have been classified as appropriate by the attending ophthalmologist, with 14% being false positives.

“The findings [also] indicate that more than half (53%) of the referrals to ophthalmology in 2019 were new referrals. This closely aligns with the findings of the Blue Mountains Eye Study from 1992-1994,” the report stated.

“Furthermore, new glaucoma diagnoses made up the majority of referrals for those under the age of 49; 72.8% for people under the age of 40 and 68.7% for people 40 to 49.”

While the systematic use of OCT has been the catalyst for significant changes to patient care, Specsavers states the introduction of other clinical interventions are also having a measurable impact.

This includes increased utilisation and same day performance of visual fields on at-risk patients, use of the RANZCO Referral Pathways, the Oculo e-referral platform and Optometry Benchmark Reporting.

Another contributing factor has been the ophthalmology-led education workshops that were recently introduced for Specsavers optometrists. Glaucoma referrals have increased by 35% in practices that have attended the program while also reducing the level of false-positive results.

Tackling diabetic eye disease

Specsavers has also recorded a major rise in diabetic retinopathy detection levels. At 31 July, 7,028 patients were referred to ophthalmology for the disease. Based on the current referral rates, this figure is projected to reach 12,000 patients by the end of the year, an increase of 34% on 2018 (8,982) and 205% on 2017 (3,931).

“This year, following enhancements to Specsavers’ patient management system to enable optometrists to simply and consistently identify patients with diabetes, and the introduction of the KeepSight portal, for the first time we are able to properly start measuring eye health outcomes for this subset of the total population,” the report said.

“The ability to analyse data specifically for patients with diabetes opens up many opportunities to better understand eyecare for this at-risk group as it currently stands, which will provide direction and impetus to enhance standards of care and accessibility.”

Specsavers is currently registering 1,500 diabetes patients every week to the KeepSight database to ensure they get regular reminder to get their eyes checked. Total registrations from Specsavers optometrists are forecast to reach 36,000 by the end of the year.

Glaucoma referrals to ophthalmology are projected to reach 42,000 by the end of the year.

 

Specsavers’ glaucoma referrals are aligning with national prevalence rates as detailed in the Blue Mountains Eye Study.

 

Specsavers expects to make 12,000 diabetic eye referrals by the end of the year, an increase of 34% on 2018 (8,982) and 205% on 2017 (3,931).
Tags: diabetic retinopathyeye healthglaucomaKeepSightOCTOculoophthalmologyoptical cohernece tomographyRANZCOSpecsavers

Related Posts

A new WA clinic will give Aboriginal communities and others greater access to eyecare. Image: Sawoon/stock.adobe.com

New clinic will help address inequities in Aboriginal eyecare

by Staff Writer
December 5, 2024

A new eye clinic aims to make a significant impact in transforming eyecare for Aboriginal communities in Western Australia. A...

Or lack of it, depending on where you live, is the concern of the CPMC and others. Image: BJP7images/stock.adobe.com.

Health ministers warned that fast-track changes could bring ‘postcode’ health care

by Staff Writer
December 5, 2024

Australia’s state health ministers have been warned that the proposed fast-track registration of Specialist International Medical Graduates (SIMGs) risks exacerbating...

Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited